Zhytomyr, Ukraine Clinical Trials

A listing of Zhytomyr, Ukraine clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 28 clinical trials
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

The GLORIA study is a Phase III, randomized, open-label study to prospectively evaluate the efficacy and safety of adagloxad simolenin (OBI 822)/OBI-821 in the adjuvant treatment of patients with high risk, early stage Globo-H Positive TNBC.

metastasis
cancer
epidermal growth factor
estrogen receptor
capecitabine
Medical Center Verum
 (83.0 away) Contact site
  • 309 views
  • 21 Oct, 2020
  • +114 other locations
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

The purpose of this study is to evaluate the effect of TRC101 on the progression of chronic kidney disease (CKD) and to evaluate the safety profile of TRC101 in CKD patients with metabolic acidosis.

nephropathy
glomerular filtration rate
ace inhibitor
Investigative Site 2706
 (83.0 away) Contact site
  • 316 views
  • 17 Sep, 2020
  • +481 other locations
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. …

cardiovascular disease
overweight or obesity
body mass index
Novo Nordisk Investigational Site
 (70.8 away) Contact site
  • 7712 views
  • 25 Nov, 2020
  • +1155 other locations
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

endoscopy
abdominal pain
ileal disease
corticosteroids
First Private Clinic
 (0.7 away) Contact site
  • 865 views
  • 06 Sep, 2020
  • +418 other locations
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

This study [contRAst 1 (201790: NCT03980483)] is a phase 3, randomized, multicenter, double blind study to assess the safety and efficacy of GSK3196165, in combination with methotrexate (MTX), for the treatment of adult participants with moderate to severe active rheumatoid arthritis (RA) who have had an inadequate response to MTX. …

arthralgia
methotrexate
tofacitinib
erosion
GSK Investigational Site
 (70.8 away) Contact site
  • 488 views
  • 23 Sep, 2020
  • +182 other locations
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on …

chronic disease
semaglutide
stroke
Novo Nordisk Investigational Site
 (83.0 away) Contact site
  • 1276 views
  • 26 Nov, 2020
  • +550 other locations
A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

The proposed study is a randomized, double-blind,placebo-controlled, multi-center phase II study to investigatethe safety and efficacy of SHR0302 in patients with moderate to severe activeulcerative colitis. The study aims to evaluate the optimal dose of SHR0302 andtime needed in inducing clinical response in active ulcerative colitispatients. This is an 8+8 …

endoscopy
CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM
 (70.8 away) Contact site
  • 92 views
  • 19 Nov, 2020
  • +106 other locations
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199) With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.

venetoclax
acalabrutinib
abt-199
chemoimmunotherapy
obinutuzumab
Research Site
 (83.0 away) Contact site
  • 342 views
  • 04 Nov, 2020
  • +236 other locations
Pivotal Study to Assess the Efficacy Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation

Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) as measured by Annualized rate of acute moderate and severe COPD exacerbation (AECOPD) Secondary Objectives: To evaluate the effect of dupilumab administered every 2 weeks on Pre-bronchodilator forced …

muscarinic antagonists
bronchodilator
cough
dyspnea
corticosteroids
Investigational Site Number 8040005
 (70.8 away) Contact site
  • 1142 views
  • 25 Nov, 2020
  • +441 other locations
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

The purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).

mycophenolate
antimalarials
antinuclear antibody
chloroquine
prednisone
Private Small Scale Medical Center Pulse
 (70.8 away) Contact site
  • 247 views
  • 01 Nov, 2020
  • +251 other locations